Sidekick Health chosen for White House’s CancerX project
Sidekick Health, Alumni company within the Accelerator at Sahlgrenska Science Park and member of HealthTech Nordic, has been recognized as an international champion of digital health research and innovation, and chosen to partner for the White House's CancerX initiative announced by U.S. President Joe Biden and Dr. Jill Biden. The aim is to rapidly accelerate the pace of cancer innovation in the US.
The company has made an amazing journey. Starting off with a handful of people at Sahlgrenska Science Park, still part of the community as well as the HealthTech Nordic community, the company now has offices in Boston, Berlin, Reykjavik, and Stockholm.
Sidekick Health is one of 15 organizations chosen to help tackle the root causes of health inequity and accelerate digital innovation to solve some of the most pressing challenges facing patients with cancer.
Sidekick Health will work on the inaugural CancerX project, “Advancing Digital Innovation to Improve Equity and Reduce Financial Toxicity in Cancer Care and Research” that will champion the value of digital solutions in cancer to solve some of the field’s most pressing challenges. Sidekick Health will share their cutting-edge expertise already gained from providing a tailored digital health program to people living with breast cancer.
Read more about the partnership
Read more about HealthTech Nordic
Photo: Saemundur "Sam" Oddsson, Co-founder and Chief Clinical Officer at SidekickHealth
The initiative Next Stop gives detailed overview of the structure, collaboration and funding opportunties with leading partners of the world’s largest healthcare markets.
Inkubatorer i Västsverige ser en positiv trend för kvinnligt entreprenörskap. De senaste åren har närmare 10% fler kvinnor deltagit i de ...
Exciting news from the Accelerator
The first episode of the interview podcast Klara, Färdiga, Entreprenör is released, where West Swedish entrepreneurs talk about their inn...
Elypta, part of the Accelerator at Sahlgrenska Science Park, raises $21 million Series A to develop metabolism-based multi-cancer early detection test.